Abstract
Importance: Evidence on physical activity recommendations for inflammatory bowel disease (IBD) patients is limited, with concerns about high-intensity activity. Objective: To investigate the associations of accelerometer-measured moderate-to-vigorous physical activity (MVPA) with bowel resection risk and mortality among individuals with IBD. Design, setting, and participants: This longitudinal cohort study collected data from 1,303 UK Biobank participants with IBD diagnosis and device-measured physical activity from 2013 to 2015, with follow-up data examined until 2022. Exposures: MVPA was classified based on data measured by wrist-worn accelerometers over a 7-day period. MVPA patterns were defined as inactive (< 150 minutes/week), active weekend warrior (≥ 150 minutes/week, ≥50% of total MVPA achieved in 1-2 days), and regularly active (≥150 minutes/week, not active weekend warrior). Main Outcomes and Measures: The bowel resection was identified through operational records from hospital inpatient data of the National Health Service. Deaths were documented through linkage to the national death register. Associations were estimated using multivariable Cox regression models and nonlinearity was assessed by restricted cubic spline. Results: During a median follow-up of 7.8 years, 56 incident bowel resection cases and 86 deaths were documented. After multivariable adjustment, participants in the highest tertile of MVPA duration had lower risks of bowel resection (HR, 0.44; 95% CI, 0.22-0.86) and mortality (HR, 0.49; 95% CI, 0.27- 0.89) compared to those in the lowest tertile. MVPA duration is linearly associated with bowel resection (P non-linear = 0.13) while its dose-response relationship with mortality plateaus at approximately 58 min/day (P non-linear = 0.02). Regarding MVPA patterns, the active weekend warrior pattern was inversely associated with bowel resection risk (HR, 0.28; 95% CI, 0.12-0.65), the regularly active pattern was inversely associated with both bowel resection risk (HR, 0.37; 95% CI, 0.19-0.69) and mortality (HR, 0.53; 95% CI, 0.31-0.91) compared to the inactive. Conclusion and relevance: Longer accelerometer-measured MVPA was associated with reduced bowel resection risk and mortality. The regularly active pattern may be the optimal choice for individuals with IBD, while the active weekend warrior pattern still provides health benefits compared to being inactive.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Dr. Zixuan He is supported by the National Natural Science Foundation of China (No.82300641); Shanghai Sailing Program (No.23YF1458700); Chenguang Program of Shanghai Education Development Foundation and Shanghai Municipal Education Commission (No.23CGA44); the Youth Start-up Fund of Naval Medical University (No.2022QN065); and Changfeng Guhai Project of Changhai Hospital (Changying Youth Seedling Plan). Prof. Xiaoyan Wang is supported by the National Natural Science Foundation of China (No. U23A20492,8217033803). Dr. Yu Bai is supported by the National Key Research and Development Program of China (No.2023YFC2413800); the National Natural Science Foundation of China (No.82170567, 81873546); and the Program of Shanghai Academic/Technology Research Leader (No. 22XD1425000).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data availability statement: the datasets analysed during the current study are available in a public, open-access repository (https://www.ukbiobank.ac.uk/).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data availability statement: the datasets analysed during the current study are available in a public, open-access repository (https://www.ukbiobank.ac.uk/).